文献速递神经肿瘤

内镜经蝶手术治疗非功能性垂体腺瘤在第九个十年(80岁以上)患者中的风险与获益

Risks and Benefits of Endoscopic Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas in Patients of the Ninth Decade.
PubMed 文献 · World Neurosurg · 2017-07-01

这项回顾性研究比较了2007至2015年间手术的80岁以上(A组15例)与65-75岁(B组49例)非功能性垂体腺瘤患者。A组完全切除率为53.3%,B组为73.5%;A组术后视力改善显著优于B组(P=0.0012);无死亡病例,两组术后并发症无差异。结论认为年龄超过80岁本身并非内镜经蝶手术预后更差的预测因素。

要点

  • 80岁以上患者完全切除率为53.3%,65-75岁组为73.5%。
  • 80岁以上组术后视力改善显著优于65-75岁组(P=0.0012)。
  • 无死亡病例,两组术后并发症无差异。

核心结论

  • 年龄超过80岁本身并非内镜经蝶手术治疗非功能性腺瘤临床结局更差的预测因素。
  • 应重视对视路减压以改善高龄患者的生活质量。

研究设计与样本

  • 回顾性研究,纳入2007年至2015年间连续手术的老年(65-75岁)与高龄(80岁以上)非功能性垂体腺瘤患者。
  • 共623例手术患者,其中307例为非功能性垂体腺瘤;65岁以上占23%(n=143),80岁以上占2.56%(n=16)。
  • 研究分组:A组15例80岁以上患者,B组49例65-75岁患者。

主要发现

  • 65岁以上患者中促性腺激素型及无免疫反应性肿瘤占81%。
  • 两组术前指标无统计学差异。
  • 完全肿瘤切除A组为53.3%,B组为73.5%。
  • 术后视力状态改善A组显著优于B组(P=0.0012)。
  • 无死亡病例,两组术后并发症无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The population older than 80 years of age (very elderly) is increasing, and the management of these patients with pituitary surgery is controversial. OBJECTIVE: To determine the prevalence of pituitary tumors in elderly patients and to determine the safety of endoscopic transsphenoidal pituitary surgery for nonfunctioning pituitary adenomas in patients aged older than 80 years. METHODS: This retrospective study included elderly (65-75 years old) and very elderly consecutive patients operated between 2007 and 2015 for nonfunctioning pituitary adenomas. Tumor characteristics, comorbidities, pre- and postoperative visual and endocrinologic status, and postoperative complications were compared. RESULTS: Of the total 623 operated patients, 307 had nonfunctioning pituitary adenomas. Twenty-three percent (n = 143) of all patients were aged older than 65 years, whereas 2.56% (n = 16) were aged older than 80 years. Gonadotroph and nonimmunoreactive tumors occurred in 81% of patients aged older than 65 years. The study groups were Group A, comprising 15 patients aged older than 80 years, and Group B, comprising 49 patients aged 65-75 years. No presurgical statistical differences were noted between the 2 groups. Complete tumor resection was achieved in 53.3% of Group A and 73.5% of Group B. Postsurgical visual status improved significantly in Group A than in Group B (P = 0.0012). No deaths occurred, and no group differences were noted in the postoperative complications. CONCLUSIONS: Age exceeding 80 years is not by itself a predictor of worse clinical outcome of endoscopic transsphenoidal pituitary surgery for nonfunctioning adenomas. Emphasis should be placed on visual pathway decompression for the quality of life in very old people.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Chinezu R, Fomekong F, Lasolle H, et al. Risks and Benefits of Endoscopic Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas in Patients of the Ninth Decade. World Neurosurg. 2017. PMID: 28676462. doi:10.1016/j.wneu.2017.06.151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。